Celso Arango, PhD

  • 9Articles
  • 42.9KReads
  • 2002–2023Active
  • 64Collaborators
  • 923Citations

About

Celso Arango, PhD, is affiliated with Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) and the Department of Child and Adolescent Psychiatry at Hospital General Universitario Gregorio Marañón and Universidad Complutense in Madrid, Spain. Since 2002, Arango has published extensively on child and adolescent psychiatry, focusing on schizophrenia, schizoaffective disorders, neurodevelopmental and psychotic disorders, and suicide. His research includes studies on early-onset psychosis, antipsychotic treatment outcomes, metabolic side effects in youth, and predictors of clinical and functional outcomes.

Publications

JCP
Neighborhood Vulnerability in First-Episode Psychosis
Original Research

Neighborhood Vulnerability in First-Episode Psychosis

March 13, 2023

Psychosocial difficulties in people with first-episode psychosis could be related to a lack of resources in the area where they live.
, , , et al
JCP
Original Research

Autism and Antipsychotic Treatment

November 7, 2017

Read this article to see if the presence of ASD limited the effectiveness of antipsychotic treatment in youth with ASD and psychosis.
, , , et al
JCP
Article

Predictors of Functional and Clinical Outcome in Early-Onset First-Episode Psychosis: The Child and Adolescent First Episode of Psychosis (CAFEPS) Study

November 25, 2015

, , , et al
JCP
Article

Predictors of Suicide Attempt in Early-Onset, First-Episode Psychoses: A Longitudinal 24-Month Follow-Up Study

November 13, 2012

, , , et al
JCP
Article

Increased Risk of Diabetes Mellitus Among Persons With Psychotic Symptoms: Results From the WHO World Health Survey

December 15, 2011

, , , et al
JCP
Article

Predominance of Symptoms Over Time in Early-Onset Psychosis: A Principal Component Factor Analysis of the Positive and Negative Syndrome Scale

March 15, 2010

, , , et al
JCP
Original Research

Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study

November 3, 2009

, , , et al
JCP
Article

Metabolic and Hormonal Side Effects in Children and Adolescents Treated With Second-Generation Antipsychotics

July 31, 2008

, , , et al
JCP
Letter to the Editor

High Degree of Tolerability for Monotherapy With High Doses of Quetiapine: A Case Report

November 1, 2002

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe